Manufacture of morphine sulfate pellets task order 03, FY23
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
Murty Pharmaceuticals, Inc. UEI DNJBTJ3XBQM6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $245,582
Award facts
- Contract value 100% obligated
- $245,582.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, KY 40509, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $245,582 |
About this award
This is a firm fixed-price delivery order issued under an existing indefinite delivery contract between Murty Pharmaceuticals, Inc. and the National Institute on Drug Abuse (NIDA), a civilian agency. The contract has a ceiling value of $245,582.00 and tasks Murty Pharmaceuticals with the manufacture of morphine sulfate pellets in support of NIDA's efforts to develop medications for substance use disorders. The work is to be performed at Murty Pharmaceuticals' facility in Lexington, Kentucky and will involve cGMP manufacturing, quality control testing, and stability assessments. Murty Pharmaceuticals, a minority-owned small disadvantaged business, also holds an IDIQ contract with a potential value of $7 million from NIDA for pharmaceutical development and manufacturing, as well as a $45 million IDIQ contract from the National Institutes of Health for drug formulation and manufacturing.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to Murty Pharmaceuticals, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $245,582 on 75N95023F00001.
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under 75N95021D00024, an indefinite delivery contract.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award